Add BrightSurf on Google Email

University of New Mexico Health Sciences Center


UNM researchers use new machine learning method to detect self-harm history hidden in veterans’ medical records

Researchers found that diagnosis codes captured only about one-fourth of clinically documented self-harm history, highlighting a common gap in health systems. A new study used a novel machine learning method, PULSNAR, to estimate the probability of self-harm history present but missing from diagnosis codes.

SourceUniversity of New Mexico Health Sciences Center·JournalJournal of Medical Internet Research·TypeData/statistical analysis·DateJun 5, 2026

Researchers study whether intentionally manipulating blood carbon dioxide levels might enhance brain health

A team of researchers found that intentionally raising and lowering blood CO2 levels through rhythmic exposure or controlled breathing may boost the glymphatic system's effectiveness. This approach could preserve brain function, improve cognition, and reduce cognitive decline in Parkinson's patients.

Life-long burden

Early life adversity disrupts activity across multiple brain networks when threats are encountered later in life, according to a new study published in the Proceedings of the National Academy of Sciences. The study found that mice subjected to adversity in infancy showed abnormal brain activity in response to threats as adults.

SourceUniversity of New Mexico Health Sciences Center·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 11, 2025

Vascular disease is an overlooked contributor to dementia, UNM researcher finds

A UNM researcher has identified 10 disease processes that contribute to vascular-based brain injury, including effects of nano- and microplastics. The findings suggest a potential half of Alzheimer's patients may also have vascular disease, paving the way for new classification and treatment approaches.

SourceUniversity of New Mexico Health Sciences Center·JournalAmerican Journal Of Pathology·TypeObservational study·DateSep 19, 2025

UNM researchers receive funding to launch clinical trial of a new Alzheimer’s vaccineUNM researchers receive funding to launch clinical trial of a new Alzheimer’s vaccine

Researchers at the University of New Mexico are launching a Phase 1a/1b clinical trial for a new vaccine engineered to clear pathological tau protein from the brains of patients with Alzheimer’s dementia. The trial aims to assess the safety and immunogenicity of the novel vaccine.

Over decades, a healthy lifestyle outperforms metformin in preventing onset of Type 2 diabetes

A new study confirms that intensive lifestyle modification is more effective than metformin in preventing the onset of Type 2 diabetes. The health benefits from lifestyle intervention persisted for over 20 years, with participants experiencing a reduced risk of developing diabetes compared to those on metformin.

SourceUniversity of New Mexico Health Sciences Center·JournalThe Lancet Diabetes & Endocrinology·TypeRandomized controlled/clinical trial·DateJul 2, 2025

Treating patients for opioid use disorder in the hospital leads to better outcomes after they are discharged, study finds

A new study finds that treating hospitalized patients with opioid use disorder leads to better outcomes after discharge. The program, which pairs patients with treatment programs and medication, increases the likelihood of follow-up care and reduces hospital stay length.

SourceUniversity of New Mexico Health Sciences Center·JournalJAMA Internal Medicine·TypeRandomized controlled/clinical trial·DateApr 8, 2025

UNM scientists discover how nanoparticles of toxic metal used in MRI scans infiltrate human tissue

Researchers have found that oxalic acid can generate nanoparticles of the toxic metal gadolinium in human tissues, which has been associated with serious health problems such as nephrogenic systemic fibrosis. This discovery may lead to a possible way to mitigate some of the risks associated with MRI scans.

“Concierge” screening for kidney transplant candidates leads to better outcomes, UNM researcher finds

A new 'concierge' approach called the Kidney Transplant Fast Track enables more people to receive transplants and erases racial disparities. This streamlined process coordinates testing onsite and often performed by the transplant center, increasing patient suitability and reducing wait times.

SourceUniversity of New Mexico Health Sciences Center·JournalJAMA Internal Medicine·TypeCase study·DateMar 21, 2025

Study offers new hope for relieving chronic pain in dialysis patients

A new randomized controlled trial found that pain coping skills training (PCST) significantly reduced chronic pain in dialysis patients, enabling them to perform daily activities with less interference. PCST, a 12-week coaching session followed by automated voice response sessions, addressed pain-related anxiety and stress.

SourceUniversity of New Mexico Health Sciences Center·JournalJAMA Internal Medicine·TypeRandomized controlled/clinical trial·DateJan 31, 2025

UNM researchers find microplastics in canine and human testicular tissue

A study published in Toxicological Sciences found significant concentrations of microplastics in both human and canine testicular tissue, with polyethylene and PVC being the most prevalent polymers. The research suggests a potential link between microplastic exposure and reduced sperm count, particularly in dogs.

SourceUniversity of New Mexico Health Sciences Center·JournalToxicological Sciences·TypeExperimental study·DateMay 15, 2024

Even moderate alcohol usage during pregnancy linked to birth abnormalities, UNM researchers find

UNM researchers found that even low to moderate alcohol use during pregnancy can contribute to subtle changes in prenatal development, including lower birth length and shorter gestation duration. Sex-specific differences were also observed, with male infants affected more by the effects of drinking during pregnancy.

SourceUniversity of New Mexico Health Sciences Center·JournalAlcohol Clinical and Experimental Research·TypeObservational study·DateApr 2, 2024

Commonly used insomnia treatments fail to help dialysis patients, UNM Health Sciences research finds

A new study tested cognitive behavioral therapy and trazodone for treating sleeplessness in dialysis patients, finding no meaningful difference in symptoms. The researchers suggest that multiple medical conditions and medication interactions may be driving the insomnia.

SourceUniversity of New Mexico Health Sciences Center·JournalAnnals of Internal Medicine·TypeRandomized controlled/clinical trial·DateFeb 23, 2024

Microplastics in every human placenta, new UNM Health Sciences research discovers

A recent study by UNM Health Sciences researchers has found that microplastics are present in all 62 human placenta samples tested. The concentrations ranged from 6.5 to 790 micrograms per gram of tissue, with polyethylene being the most prevalent polymer found. The study suggests that microplastics may be linked to puzzling increases ...

SourceUniversity of New Mexico Health Sciences Center·JournalToxicological Sciences·TypeExperimental study·DateFeb 20, 2024

U.S. drinking water often contains toxic contaminants, UNM scientist warns

A new study finds that many wells and community water systems in the US contain unsafe levels of toxic contaminants, including cancer-causing substances like arsenic and lead. Climate change will exacerbate the issue, particularly in underserved communities, as clean sources of drinking water become harder to find.

SourceUniversity of New Mexico Health Sciences Center·JournalJournal of Exposure Science & Environmental Epidemiology·TypeSystematic review·DateOct 4, 2023

Native American patients were sicker and more likely to die during the COVID-19 pandemic, UNM researchers find

Researchers found that Native American patients were sicker and more likely to die in the hospital due to COVID-19, despite having fewer pre-existing conditions. They also had higher viral loads in their blood, which may be linked to immunological responses or social determinants of health.

SourceUniversity of New Mexico Health Sciences Center·JournalPNAS Nexus·TypeObservational study·DateSep 1, 2023

Troubling discovery

Researchers found that gadolinium nanoparticles from MRI contrast agents can infiltrate kidney cells, causing severe side effects like nephrogenic systemic fibrosis. The study used electron microscopy to detect tiny deposits of gadolinium in the kidneys of people who had been injected with contrast agents prior to their MRIs.

SourceUniversity of New Mexico Health Sciences Center·JournalScientific Reports·TypeExperimental study·DateFeb 16, 2023

Endothelial exploration

Researchers have identified a new protein in the cerebrospinal fluid that can reliably detect endothelial injury, a key contributor to cognitive impairment in pre-symptomatic stages of Alzheimer's. The discovery offers hope for improving diagnostic tests and potentially preventing damage to the brain endothelium.

SourceUniversity of New Mexico Health Sciences Center·JournalAnnals of Clinical and Translational Neurology·TypeRandomized controlled/clinical trial·DateFeb 8, 2023

Effective Prevention

A new study published in BMJ Open found that COVID vaccines are more effective in areas with higher infection rates, highlighting the need for targeted vaccine distribution. The researchers calculated absolute risk reduction and number needed to be vaccinated, revealing significant differences in effectiveness across geographical regions.

SourceUniversity of New Mexico Health Sciences Center·JournalBMJ Open·TypeData/statistical analysis·DateDec 12, 2022

Think piece

Researchers have developed a new MRI technique that captures the brain's function during normal behavior, revealing its activities on a scale previously unknown. This 'time-lapse' imaging method, called manganese-enhanced MRI (MEMRI), uses manganese as a contrast agent to highlight brain cell activity and neural projections.

SourceUniversity of New Mexico Health Sciences Center·JournalNMR in Biomedicine·TypeExperimental study·DateApr 11, 2022

Pandemic protection

A new study published in BMJ Evidence-Based Medicine found that vaccines are most effective when distributed in areas with the highest baseline risks. The researchers used absolute risk reduction to guide the equitable distribution of COVID-19 vaccines, prioritizing counties and states with lower numbers needed to vaccinate (NNV).

SourceUniversity of New Mexico Health Sciences Center·JournalBMJ Evidence-Based Medicine·TypeData/statistical analysis·DateMar 8, 2022

Particulate peril

A recent study published in Toxicological Sciences suggests that exposure to wildfire smoke can lead to premature aging, dementia, depression, and psychosis. Researchers found that tiny particles from woodsmoke can travel thousands of miles and reach the brain, causing age-related changes in brain tissue.

SourceUniversity of New Mexico Health Sciences Center·JournalToxicological Sciences·TypeExperimental study·DateDec 6, 2021

Remote responders

A new study by UNM researchers found that patients treated in rural emergency departments had similar outcomes to those receiving care in urban EDs for life-threatening conditions. However, rural patients with vague symptoms fared worse due to limited diagnostic capabilities and transfer processes.

SourceUniversity of New Mexico Health Sciences Center·JournalJAMA Network Open·TypeCase study·DateNov 23, 2021

Viral Visitation

Researchers at UNM's AIM Center have discovered how SARS-CoV-2 coronavirus interferes with the autophagy process, a vital cellular mechanism for recycling debris and invading microorganisms. The study found that the virus hijacks cellular membranes to evade immune systems.

SourceUniversity of New Mexico Health Sciences Center·JournalCell·TypeExperimental study·DateNov 22, 2021

Testing troubles

A study by University of New Mexico researchers found that 65% of women with a normal prior co-test had undergone re-screening within three years, far more often than recommended. Meanwhile, some women were not re-tested for over five years after a negative co-test or cytology alone, increasing their risk for poor outcomes.

Speeding new treatments

Researchers at the University of New Mexico Health Sciences Center have created a powerful computational tool called REDIAL-2020. This online suite of models enables scientists to quickly identify small molecules capable of disarming COVID-19, narrowing the field for future experiments and accelerating the discovery process.

SourceUniversity of New Mexico Health Sciences Center·JournalNature Machine Intelligence·DateMay 3, 2021

Solving a puzzle

Tuberous sclerosis complex (TSC) affects millions worldwide, causing cysts and benign tumors to form in the kidney, leading to kidney failure. Researchers led by Dr. Manoocher Soleimani found that changes in cells lining the collecting ducts are responsible for cyst formation, offering new avenues for potential treatments.

SourceUniversity of New Mexico Health Sciences Center·JournalProceedings of the National Academy of Sciences·DateFeb 3, 2021

Drug repurposing

University of New Mexico researchers have identified three medications with potential to treat SARS-CoV-2 infection: amodiaquine, zuclophentixol, and nebivolol. These drugs showed promise in test tube experiments and could be combined with remdesivir for a more potent attack.

SourceUniversity of New Mexico Health Sciences Center·JournalACS Pharmacology & Translational Science·DateOct 16, 2020

Aiming for accuracy

Researchers say AI and machine learning can help improve the peer review process by detecting discrepancies in research papers. With many COVID-19 studies published without thorough review, AI-powered tools may be able to analyze large amounts of data and identify patterns that human reviewers might miss.

SourceUniversity of New Mexico Health Sciences Center·JournalNature Biotechnology·DateSep 15, 2020

Circular reasoning

Researchers discovered that lower circHomer1a levels in the brain's frontal cortex are correlated with schizophrenia symptoms and impaired cognitive flexibility in mice. The study suggests that circular RNAs play a crucial regulatory role in gene expression, potentially serving as biomarkers for diagnosis and treatment targets.

SourceUniversity of New Mexico Health Sciences Center·JournalMolecular Psychiatry·DateFeb 12, 2020

Fat-fighting drug discovery

A University of New Mexico Health Sciences Center-led research team has discovered a cancer-fighting compound that also reduces fat in obese mice. The team found that the compound, G-1, increases energy expenditure and targets brown fat cells, leading to weight loss and improved diabetes symptoms.

SourceUniversity of New Mexico Health Sciences Center·JournalScience Translational Medicine·DateFeb 6, 2020

How many rare diseases are there?

Researchers estimate that there may be as many as 10 million people worldwide suffering from a rare disease, which is likely to hinder treatment development due to inconsistent and imprecise definitions. The study calls for a unified definition of rare diseases to improve care for patients and develop effective treatments.

SourceUniversity of New Mexico Health Sciences Center·JournalNature Reviews Drug Discovery·DateFeb 4, 2020